tid,label,token
57798471,ORG,Delhi High Court
57798471,ORG,Cipla Ltd.
57798471,ORG,F.Hoffmann-La Roche Ltd. & Anr.
57798471,DATE,27 November
57798471,DATE,2015
57798471,PERSON,Pradeep Nandrajog
57798471,DATE,"August 12, 2015"
57798471,DATE,"November 27, 2015"
57798471,CARDINAL,92/2012
57798471,ORG,F.HOFFMANN-LA ROCHE LTD & ANR
57798471,PERSON,Mr.Pravin Anand
57798471,PERSON,Mr.Shrawan Chopra
57798471,PERSON,"Prachi
                                    Agarwala"
57798471,PERSON,Archana Shanker
57798471,PERSON,Mr.Mahabir
57798471,PERSON,Mr.Vibhav Mithal
57798471,ORG,CIPLA LTD
57798471,PERSON,Mr.Arvind Nigam
57798471,PERSON,"Ms.Prathiba
                                           M.Singh"
57798471,ORG,Sr.Advocates
57798471,PERSON,Ms.Bitika Sharma
57798471,PERSON,Jaya Mandella
57798471,PERSON,Ms.Anusuya Nigam
57798471,CARDINAL,103/2012
57798471,ORG,CIPLA LTD
57798471,PERSON,Mr.Arvind Nigam
57798471,PERSON,"Ms.Prathiba
                                           M.Singh"
57798471,ORG,Sr.Advocates
57798471,PERSON,Ms.Bitika Sharma
57798471,PERSON,Jaya Mandella
57798471,PERSON,Ms.Anusuya Nigam
57798471,ORG,F.HOFFMANN-LA ROCHE LTD & ANR
57798471,PERSON,Mr.Pravin Anand
57798471,PERSON,Mr.Shrawan Chopra
57798471,PERSON,"Prachi
                                    Agarwala"
57798471,PERSON,Archana Shanker
57798471,PERSON,Mr.Mahabir
57798471,PERSON,Mr.Vibhav Mithal
57798471,CARDINAL,1
57798471,CARDINAL,106
57798471,ORG,"PRADEEP NANDRAJOG, J. & MUKTA GUPTA"
57798471,GPE,J
57798471,CARDINAL,1\
57798471,ORDINAL,first
57798471,ORG,Roche
57798471,ORG,Roche
57798471,DATE,"March 31, 1991"
57798471,GPE,USA
57798471,PRODUCT,"Erlotinib
Hydrochloride"
57798471,GPE,US
57798471,CARDINAL,498
57798471,DATE,"August 05, 1998"
57798471,GPE,USA
57798471,DATE,"March 13, 1996"
57798471,GPE,India
57798471,CARDINAL,774
57798471,DATE,"February 23, 2007"
57798471,ORG,Roche
57798471,DATE,"November 09, 2000"
57798471,GPE,USA
57798471,GPE,US
57798471,CARDINAL,221
57798471,GPE,India
57798471,DATE,"February 06, 2002"
57798471,ORG,DEL ‗507
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,DATE,February 2007
57798471,ORG,"the Controller
of Patents"
57798471,PRODUCT,Claim No.1
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,CARDINAL,2
57798471,PERSON,Sh.Pravin Anand
57798471,ORG,RFA
57798471,CARDINAL,103/2012
57798471,CARDINAL,2
57798471,WORK_OF_ART,106 Roche and Sh.Arvind Nigam
57798471,PERSON,Ms.Pratibha M.Singh
57798471,WORK_OF_ART,Sr.Advocate
57798471,PERSON,Cipla
57798471,LAW,the Patents Act
57798471,DATE,1970
57798471,CARDINAL,two
57798471,CARDINAL,3\
57798471,CARDINAL,4\
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,DATE,January 2008
57798471,ORG,Roche
57798471,ORG,Court
57798471,PRODUCT,Cipla
57798471,PRODUCT,Erlocip
57798471,CARDINAL,5
57798471,ORG,Roche
57798471,PERSON,Cipla
57798471,ORG,Court
57798471,DATE,"March 19, 2008"
57798471,DATE,"2008) 37
PTC 71"
57798471,ORG,Del) F Hoffman-La Roche v. Cipla Ltd
57798471,CARDINAL,103/2012
57798471,CARDINAL,3
57798471,CARDINAL,106
57798471,CARDINAL,6
57798471,ORG,Roche
57798471,ORG,the Division Bench of this Court
57798471,DATE,"April 24, 2009"
57798471,LAW,the Patents Act
57798471,DATE,1970
57798471,CARDINAL,two
57798471,DATE,2009) 40
57798471,ORG,Del) F Hoffman-La Roche v. Cipla Ltd
57798471,CARDINAL,7\
57798471,ORG,the Division Bench
57798471,ORG,Cipla
57798471,CARDINAL,774
57798471,LAW,IN ‗774
57798471,ORG,Roche
57798471,ORG,"the
Supreme Court"
57798471,CARDINAL,9
57798471,CARDINAL,two
57798471,ORDINAL,first
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,ORDINAL,second
57798471,ORG,Cipla
57798471,PRODUCT,Erlocip
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,CARDINAL,10\
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,ORG,Cipla
57798471,LAW,IN ‗774
57798471,CARDINAL,two
57798471,ORDINAL,first
57798471,PERSON,Cipla
57798471,CARDINAL,774
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,CARDINAL,774
57798471,CARDINAL,two
57798471,PERSON,Cipla
57798471,CARDINAL,774
57798471,LAW,Example 51
57798471,CARDINAL,774
57798471,CARDINAL,103/2012
57798471,CARDINAL,4
57798471,CARDINAL,106
57798471,LAW,EP ‗226
57798471,CARDINAL,774
57798471,ORDINAL,Second
57798471,PERSON,Cipla
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,ORDINAL,third
57798471,CARDINAL,3
57798471,GPE,Cipla
57798471,CARDINAL,226
57798471,CARDINAL,five
57798471,CARDINAL,11\
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,CARDINAL,774
57798471,CARDINAL,851
57798471,CARDINAL,774
57798471,ORG,Roche
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,CARDINAL,five
57798471,CARDINAL,774
57798471,LAW,EP ‗226
57798471,CARDINAL,226
57798471,CARDINAL,6
57798471,CARDINAL,7
57798471,CARDINAL,3
57798471,CARDINAL,103/2012
57798471,CARDINAL,5
57798471,CARDINAL,106
57798471,CARDINAL,12
57798471,LAW,the Patent Act
57798471,DATE,1970
57798471,ORG,"the
Supreme Court"
57798471,ORG,"AIR 1982 SC 1444 Bishwanath Prasad Radhey Shyam Vs.
Hindustan Metal Industries"
57798471,LAW,the Patent Act
57798471,DATE,1970
57798471,GPE,England
57798471,ORG,Wales Court of Appeals
57798471,DATE,2010
57798471,ORG,"RPC 9
Dr.Reddy‟s Laboratories (UK) Ltd."
57798471,ORG,Eli Lilly & Co. Ltd.
57798471,PERSON,Single Judge
57798471,PERSON,Roughton et al's
57798471,WORK_OF_ART,The Modern Law of Patents
57798471,GPE,India
57798471,GPE,US
57798471,NORP,European
57798471,DATE,1972
57798471,ORG,RPC 346 Technograph Vs. Mill & RFA
57798471,CARDINAL,103/2012
57798471,CARDINAL,6
57798471,CARDINAL,106
57798471,DATE,1985
57798471,ORG,RPC 59 Windsurfing International Inc.
57798471,ORG,"Tabur Marine
(Great Britain) Ltd."
57798471,DATE,1972
57798471,CARDINAL,457
57798471,ORG,General Tire & Rubber Co.
57798471,CARDINAL,670
57798471,GPE,Daiichi
57798471,ORG,Sankyo Vs. Matrix Laboratories & Ors.
57798471,CARDINAL,550
57798471,CARDINAL,398
57798471,DATE,2007
57798471,ORG,KSR International Co. Vs. Teleflex Inc.
57798471,ORG,TSM
57798471,NORP,Indian
57798471,CARDINAL,13\
57798471,LAW,Section 64
57798471,LAW,Section 2(ja) of the Patent Act
57798471,DATE,1970
57798471,LAW,Section 2
57798471,CARDINAL,14
57798471,CARDINAL,two
57798471,ORG,Section
57798471,CARDINAL,15
57798471,LAW,The Modern Law of Patents
57798471,CARDINAL,103/2012
57798471,CARDINAL,7
57798471,CARDINAL,106
57798471,CARDINAL,16
57798471,ORDINAL,first
57798471,PERSON,Cipla
57798471,CARDINAL,two
57798471,ORG,Roche
57798471,ORG,Single Judge
57798471,PERSON,Cipla
57798471,PERSON,Cipla
57798471,ORG,Cipla‟s
57798471,PERSON,Single Judge
57798471,CARDINAL,226
57798471,ORG,Roche
57798471,PRODUCT,Geftinib
57798471,CARDINAL,103/2012
57798471,CARDINAL,8
57798471,CARDINAL,106
57798471,ORG,Tarceva
57798471,CARDINAL,17
57798471,CARDINAL,One
57798471,PERSON,Cipla
57798471,CARDINAL,five
57798471,PERSON,Cipla
57798471,CARDINAL,two
57798471,CARDINAL,one
57798471,ORG,Cipla
57798471,CARDINAL,two
57798471,CARDINAL,four
57798471,CARDINAL,five
57798471,CARDINAL,6
57798471,CARDINAL,18\
57798471,ORG,Cipla
57798471,CARDINAL,19
57798471,ORDINAL,second
57798471,ORG,Cipla
57798471,CARDINAL,3
57798471,CARDINAL,774
57798471,ORG,Roche
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,CARDINAL,507
57798471,ORG,the Controller of Patents
57798471,DATE,December 2008
57798471,LAW,EP 226
57798471,ORG,Cipla
57798471,ORG,RFA
57798471,CARDINAL,9
57798471,CARDINAL,106
57798471,CARDINAL,3
57798471,CARDINAL,774
57798471,LAW,EP ‗226
57798471,LAW,"Single Judge rules against
Cipla"
57798471,CARDINAL,774
57798471,LAW,Example 51 of EP ‗226
57798471,LAW,"IN
‗774"
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,LAW,IN ‗774
57798471,LAW,Section 3
57798471,CARDINAL,20\
57798471,CARDINAL,774
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,CARDINAL,one
57798471,LAW,Section 8
57798471,LAW,Section 8 of the Patents Act
57798471,DATE,1970
57798471,GPE,India
57798471,ORG,Court
57798471,DATE,2009) 41
57798471,ORG,"PTC
260 (Del) Chemtura Corporation v Union of India"
57798471,ORG,Chemtura
57798471,CARDINAL,10
57798471,CARDINAL,106
57798471,LAW,IN ‗774
57798471,LAW,Section 8 of the Act
57798471,CARDINAL,22.8.2006
57798471,GPE,US
57798471,CARDINAL,221
57798471,LAW,Section 64
57798471,CARDINAL,1
57798471,LAW,Section 64
57798471,CARDINAL,1
57798471,ORG,Single Jude
57798471,ORG,Roche
57798471,ORG,Section
57798471,CARDINAL,21
57798471,ORG,Roche
57798471,CARDINAL,22
57798471,ORG,Erlotinib Hydrochloride
57798471,ORG,Tarceva
57798471,CARDINAL,774
57798471,PRODUCT,Tarceva
57798471,PRODUCT,Erlocip
57798471,CARDINAL,23\
57798471,ORG,Cipla
57798471,CARDINAL,774
57798471,PRODUCT,B of Erlotinib Hydrochloride
57798471,PRODUCT,Tarceva
57798471,GPE,US
57798471,CARDINAL,221
57798471,LAW,DEL ‗507
57798471,CARDINAL,24
57798471,ORG,Roche
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,PRODUCT,the Claim 1
57798471,CARDINAL,774
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,CARDINAL,103/2012
57798471,CARDINAL,11
57798471,CARDINAL,106
57798471,PRODUCT,Hydrochloride
57798471,PRODUCT,Polymorph B
57798471,PRODUCT,Cipla
57798471,PRODUCT,Claim 1
57798471,CARDINAL,774
57798471,PRODUCT,Polymorph B
57798471,ORDINAL,first
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,Erlotinib Hydrochloride
57798471,GPE,Polymorph B
57798471,ORG,Erlotinib Hydrochloride
57798471,CARDINAL,25
57798471,CARDINAL,213
57798471,PERSON,Tarceva
57798471,ORG,the Indian Patent
57798471,PRODUCT,Polymorphic
57798471,CARDINAL,26
57798471,CARDINAL,two
57798471,ORDINAL,first
57798471,PERSON,Tarceva
57798471,ORDINAL,second
57798471,ORG,Erlotinib Hydrochloride
57798471,CARDINAL,774
57798471,CARDINAL,774
57798471,ORG,Tarceva
57798471,CARDINAL,12
57798471,CARDINAL,106
57798471,CARDINAL,27\
57798471,CARDINAL,774
57798471,WORK_OF_ART,Polymorph B of Erlotinib Hydrochloride
57798471,ORG,Erlocip
57798471,CARDINAL,28\
57798471,ORG,Roche
57798471,ORG,Erlocip
57798471,CARDINAL,774
57798471,ORG,Tarceva
57798471,CARDINAL,Two
57798471,ORG,Court
57798471,CARDINAL,228
57798471,CARDINAL,29
57798471,CARDINAL,one
57798471,CARDINAL,230
57798471,CARDINAL,30
57798471,CARDINAL,774
57798471,ORG,Tarceva
57798471,CARDINAL,31\
57798471,CARDINAL,231
57798471,ORG,Court
57798471,CARDINAL,13
57798471,CARDINAL,106
57798471,DATE,1982
57798471,ORG,"RPC 153 Catnic Components Ltd. &
Anr."
57798471,ORG,Vs. Hill & Smith Ltd.
57798471,DATE,2004
57798471,ORG,RPC Merck & Co. Inc.
57798471,ORG,Vs. Generic UK Ltd.
57798471,ORG,Single Judge
57798471,DATE,1990
57798471,ORG,FSR 181 Improver Corporation & Ors.
57798471,ORG,"Remington
Consumer Products Ltd. & Ors."
57798471,DATE,2005
57798471,ORG,RPC 9 Kirin-Amgen
57798471,ORG,"Hoechst Marion
Roussel"
57798471,CARDINAL,32
57798471,ORG,Merck
57798471,CARDINAL,14
57798471,CARDINAL,106
57798471,CARDINAL,33\
57798471,ORG,Roche
57798471,PERSON,Roche
57798471,ORG,Erlocip
57798471,CARDINAL,774
57798471,LAW,IN ‗774
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,GPE,Tarceva
57798471,WORK_OF_ART,Tarceva
57798471,PRODUCT,Polymorph B
57798471,WORK_OF_ART,Claim 1 to Polymorph B
57798471,WORK_OF_ART,Erlotinib Hydrochloride
57798471,CARDINAL,34
57798471,ORG,Roche
57798471,GPE,US
57798471,CARDINAL,221
57798471,CARDINAL,774
57798471,LAW,IN ‗774
57798471,ORG,USPTO
57798471,GPE,US
57798471,CARDINAL,221
57798471,CARDINAL,15
57798471,CARDINAL,106
57798471,PRODUCT,Tarceva
57798471,ORG,Catnic
57798471,ORG,Merck
57798471,CARDINAL,35
57798471,ORG,Controller
57798471,DATE,2008
57798471,CARDINAL,507
57798471,ORG,Controller
57798471,LAW,Section 3
57798471,CARDINAL,507
57798471,CARDINAL,774
57798471,CARDINAL,774
57798471,CARDINAL,507
57798471,CARDINAL,774
57798471,CARDINAL,277
57798471,GPE,US
57798471,GPE,US
57798471,CARDINAL,221
57798471,CARDINAL,36
57798471,CARDINAL,774
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,Polymorph B
57798471,ORG,"Erlotinib
Hydrochloride"
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,CARDINAL,260
57798471,GPE,India
57798471,GPE,US
57798471,LAW,the  RFA (OS) Nos.92/2012
57798471,LAW,"103/2012 Page 16 of
> 106"
57798471,CARDINAL,‟774
57798471,ORG,Polymorphic
57798471,CARDINAL,‟774
57798471,CARDINAL,37
57798471,ORG,Roche
57798471,CARDINAL,507
57798471,CARDINAL,507
57798471,CARDINAL,774
57798471,ORG,Erlocip
57798471,ORG,Roche
57798471,ORDINAL,first
57798471,CARDINAL,38\
57798471,GPE,Cipla
57798471,LAW,Section 3(d) of the Act
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,LAW,Act
57798471,CARDINAL,39
57798471,LAW,the Patents Act
57798471,PERSON,Cipla
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,17
57798471,CARDINAL,106
57798471,CARDINAL,2
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,LAW,Act
57798471,CARDINAL,2
57798471,CARDINAL,one
57798471,CARDINAL,3
57798471,LAW,this Act -
57798471,CARDINAL,at least one
57798471,CARDINAL,18
57798471,CARDINAL,106
57798471,CARDINAL,40\
57798471,LAW,Section 2
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,PERSON,Prathiba M.Singh
57798471,LAW,Section 2
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,41
57798471,LAW,Section 2(1
57798471,CARDINAL,19
57798471,CARDINAL,106
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,LAW,"Section
2"
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,LAW,Section 48
57798471,LAW,Section 2(1
57798471,LAW,Section 48
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,44
57798471,LAW,Act
57798471,ORG,Legislature
57798471,LAW,Section 2(1)
57798471,LAW,Section 2(1)(j)
57798471,CARDINAL,103/2012
57798471,CARDINAL,20
57798471,CARDINAL,106
57798471,GPE,India
57798471,CARDINAL,two
57798471,CARDINAL,2
57798471,LAW,Section 2(1)
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,one
57798471,CARDINAL,46
57798471,LAW,Act
57798471,ORG,Legislature
57798471,CARDINAL,47\
57798471,LAW,Section 3
57798471,LAW,the Patents (Amendment) Act
57798471,DATE,2005
57798471,ORG,Legislative
57798471,LAW,Section 3
57798471,LAW,Section 3
57798471,LAW,Section 2
57798471,CARDINAL,1
57798471,LAW,Section 2(1
57798471,LAW,Section  RFA (OS
57798471,CARDINAL,21
57798471,CARDINAL,106
57798471,CARDINAL,3\
57798471,LAW,Section 2(1
57798471,CARDINAL,48\
57798471,LAW,Sections 2
57798471,CARDINAL,1
57798471,LAW,Section 2(1)
57798471,CARDINAL,49
57798471,LAW,Section 3(d)
57798471,CARDINAL,at least one
57798471,CARDINAL,22
57798471,CARDINAL,106
57798471,CARDINAL,50
57798471,LAW,Section 3
57798471,LAW,Act
57798471,LAW,Section 3
57798471,LAW,Section 48
57798471,CARDINAL,3
57798471,CARDINAL,52
57798471,PERSON,Pratibha M.Singh
57798471,LAW,Section 3
57798471,CARDINAL,103/2012
57798471,CARDINAL,23
57798471,CARDINAL,106
57798471,LAW,Section 3(d)
57798471,LAW,Section 3(d)
57798471,ORDINAL,first
57798471,GPE,India
57798471,LAW,Section 3(d
57798471,LAW,Section 3(d
57798471,GPE,India
57798471,CARDINAL,53\
57798471,LAW,Act
57798471,CARDINAL,two
57798471,LAW,Section 3(d) of the Act
57798471,CARDINAL,three
57798471,LAW,103/2012 Page 24 of 106
57798471,ORG,Section
57798471,CARDINAL,54
57798471,CARDINAL,55
57798471,LAW,the Australian Patents Act
57798471,DATE,1990
57798471,LAW,"Schedule 1 of the Australian
Act"
57798471,CARDINAL,25
57798471,CARDINAL,106
57798471,CARDINAL,56
57798471,CARDINAL,57\
57798471,LOC,Europe
57798471,LAW,"Article 1(a) of Council Regulation (EEC) No
1768/92"
57798471,CARDINAL,58\
57798471,LAW,Article 1 (b)
57798471,LAW,the EU Regulation  RFA
57798471,CARDINAL,103/2012
57798471,LAW,Page 26 of 106
57798471,CARDINAL,60\
57798471,LAW,the Indian Patent Act
57798471,CARDINAL,61\
57798471,LAW,Section 3 of the Act
57798471,LAW,Section 2(1
57798471,ORG,Cipla
57798471,LAW,Section 2(1
57798471,LAW,Section 3
57798471,LAW,Section 3
57798471,LAW,Section 2(1)
57798471,LAW,Section 3
57798471,LAW,Section 2(1)(j)
57798471,LAW,Section 3
57798471,LAW,Section 2(1
57798471,LAW,103/2012 Page 27 of 106
57798471,LAW,Sections 2(1
57798471,LAW,Section 2(1
57798471,LAW,Section 3(d)
57798471,LAW,Act
57798471,LAW,Section 2(1)(ta
57798471,LAW,Section 3 and Section 2
57798471,CARDINAL,1
57798471,CARDINAL,one
57798471,LAW,Section 3
57798471,LAW,Section 2(1
57798471,CARDINAL,one
57798471,CARDINAL,2
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,28
57798471,CARDINAL,106
57798471,CARDINAL,63\
57798471,PRODUCT,API
57798471,CARDINAL,64
57798471,LAW,Section 3
57798471,CARDINAL,two
57798471,CARDINAL,29
57798471,CARDINAL,106
57798471,CARDINAL,65
57798471,ORG,the Supreme Court
57798471,DATE,2013
57798471,CARDINAL,6
57798471,CARDINAL,1
57798471,ORG,"Novartis AG Vs.
Union of India"
57798471,CARDINAL,88
57798471,LAW,Section 3
57798471,LAW,Section 3
57798471,LAW,Chapter II
57798471,DATE,1970
57798471,LAW,Section 3
57798471,LAW,Section 3(d) with Clauses
57798471,LAW,Section 2(1
57798471,LAW,Section 2(1
57798471,LAW,Section 3(d
57798471,LAW,Act
57798471,LAW,Act
57798471,LAW,Section 3(d
57798471,DATE,the year 2005
57798471,CARDINAL,66
57798471,DATE,1969
57798471,ORG,Bombay 255 FH & B
57798471,ORG,"Unichem
Laboratories"
57798471,ORG,Court
57798471,LANGUAGE,English
57798471,ORG,FAO
57798471,ORG,Merck Vs. Glenmark the Division Bench
57798471,CARDINAL,30
57798471,CARDINAL,106
57798471,LAW,Section 3
57798471,CARDINAL,415
57798471,PERSON,Edward H.Phillips
57798471,ORG,AWH Corporation
57798471,ORG,Court
57798471,ORG,Court
57798471,LAW,"Page 31 of
106"
57798471,MONEY,457 F.3.1284
57798471,GPE,United States
57798471,ORG,Pfizer
57798471,ORG,Court
57798471,ORG,Court
57798471,DATE,"1995 RPC
255"
57798471,GPE,UK
57798471,ORG,Glaverbel SA
57798471,ORG,British Coal Corp
57798471,ORG,Court
57798471,ORG,Court
57798471,LAW,Section 10
57798471,LAW,the Patents Act
57798471,DATE,1970
57798471,CARDINAL,ten
57798471,LAW,1st Schedule of the Act
57798471,ORG,"Manual of Patents Office
- Practice"
57798471,CARDINAL,32
57798471,CARDINAL,106
57798471,ORG,Courts
57798471,CARDINAL,One
57798471,ORDINAL,first
57798471,ORG,Patent
57798471,CARDINAL,33
57798471,CARDINAL,106
57798471,PERSON,Landis
57798471,ORG,Courts
57798471,GPE,"the United
States"
57798471,ORG,Markman
57798471,GPE,India
57798471,MONEY,517 US 370
57798471,PERSON,Herbert Markman
57798471,CARDINAL,two
57798471,ORDINAL,First
57798471,ORDINAL,Second
57798471,CARDINAL,34
57798471,CARDINAL,106
57798471,CARDINAL,three
57798471,ORDINAL,fourth
57798471,CARDINAL,three
57798471,CARDINAL,three
57798471,ORDINAL,fourth
57798471,LAW,Section 11(1
57798471,CARDINAL,68\
57798471,LAW,Claim 1 of the Suit Patent IN ‗774
57798471,CARDINAL,1
57798471,CARDINAL,6
57798471,CARDINAL,4-y1
57798471,CARDINAL,3
57798471,CARDINAL,35
57798471,CARDINAL,106
57798471,CARDINAL,69
57798471,PERSON,Pratibha M.Singh
57798471,PERSON,Cipla
57798471,PRODUCT,‗774
57798471,PRODUCT,Polymorph A+B
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Roche
57798471,GPE,USA
57798471,GPE,US
57798471,CARDINAL,221
57798471,PRODUCT,"Polymorph
B"
57798471,PRODUCT,Polymorph B
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Roche
57798471,GPE,India
57798471,ORG,Polymorph B of Erlotinib Hydrochloride
57798471,ORG,Polymorph B
57798471,ORDINAL,first
57798471,ORG,Cipla
57798471,PRODUCT,Polymorph B
57798471,CARDINAL,774
57798471,CARDINAL,70\
57798471,ORG,Roche
57798471,GPE,India
57798471,PRODUCT,DEL ‗507
57798471,PRODUCT,Polymorph B'
57798471,PRODUCT,"Erlotinib
Hydrochloride"
57798471,ORG,the Controller of Patents
57798471,DATE,December 2008
57798471,CARDINAL,36
57798471,CARDINAL,106
57798471,CARDINAL,774
57798471,CARDINAL,507
57798471,PRODUCT,Polymorph B
57798471,CARDINAL,507
57798471,CARDINAL,231102
57798471,PRODUCT,Polymorph B
57798471,CARDINAL,71
57798471,PERSON,Cipla
57798471,LAW,Section 3
57798471,LAW,the Explanation to Section 3
57798471,CARDINAL,72
57798471,LAW,Section 3
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,LAW,Section 3(d)
57798471,CARDINAL,103/2012
57798471,CARDINAL,37
57798471,CARDINAL,106
57798471,LAW,Section 48
57798471,LAW,Section 3(d)
57798471,CARDINAL,73\
57798471,LAW,Section 3
57798471,LAW,Section 3
57798471,CARDINAL,74
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Cipla
57798471,ORG,Polymorph B
57798471,CARDINAL,507
57798471,ORG,"the Indian
Patent Office"
57798471,ORG,Polymorph B
57798471,LAW,Section 2
57798471,ORG,"Polymorphs
A+B"
57798471,CARDINAL,75
57798471,CARDINAL,two
57798471,PRODUCT,Claim No.1
57798471,PRODUCT,Hydrochloride
57798471,PERSON,Cipla
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,LAW,Claim 1
57798471,CARDINAL,38
57798471,CARDINAL,106
57798471,CARDINAL,76
57798471,CARDINAL,more than one
57798471,PRODUCT,Claim-1
57798471,CARDINAL,78\
57798471,ORG,Plaintiff
57798471,ORG,Defendants
57798471,PERSON,Shashi Rekha
57798471,CARDINAL,39
57798471,CARDINAL,106
57798471,PERSON,Dr.Ashwini Nangia
57798471,CARDINAL,more than one
57798471,FAC,PX 25
57798471,ORG,Court
57798471,PERSON,Erlotinib Hydrocholoride
57798471,CARDINAL,80\
57798471,PERSON,Cipla
57798471,GPE,USA
57798471,GPE,India
57798471,PRODUCT,Erlotinib
57798471,PRODUCT,Hydrochloride
57798471,DATE,several years late
57798471,DATE,1999
57798471,DATE,1995
57798471,CARDINAL,at least two
57798471,CARDINAL,two
57798471,PRODUCT,Polymorph A
57798471,CARDINAL,103/2012
57798471,CARDINAL,40
57798471,CARDINAL,106
57798471,CARDINAL,82
57798471,CARDINAL,83\
57798471,PERSON,Shashi Rekha DW-2
57798471,CARDINAL,84
57798471,LAW,Section 3(d) of the Patents Act
57798471,CARDINAL,41
57798471,CARDINAL,106
57798471,CARDINAL,85
57798471,GPE,India
57798471,DATE,2013
57798471,CARDINAL,6
57798471,CARDINAL,1
57798471,ORG,"Novartis AG Vs.
Union of India & Ors."
57798471,CARDINAL,157
57798471,LAW,"Section
> 3"
57798471,LAW,Section 3
57798471,LAW,Section 3(d)
57798471,LAW,Section 3
57798471,DATE,2005
57798471,CARDINAL,42
57798471,CARDINAL,106
57798471,CARDINAL,86
57798471,NORP,Indian
57798471,CARDINAL,1
57798471,CARDINAL,2 and 6
57798471,CARDINAL,4
57798471,CARDINAL,3
57798471,CARDINAL,1
57798471,CARDINAL,5
57798471,CARDINAL,2
57798471,CARDINAL,3
57798471,GPE,Cipla
57798471,LAW,Section 3(d
57798471,CARDINAL,88\
57798471,ORG,Cipla
57798471,PRODUCT,X-Ray Diffraction Data
57798471,ORG,Cipla
57798471,CARDINAL,43
57798471,CARDINAL,106
57798471,DATE,the year 1999
57798471,CARDINAL,90\
57798471,ORG,Courts
57798471,DATE,1979
57798471,ORG,"American Cynamid Company Vs.
Ethicon Ltd."
57798471,PERSON,Badische Anilin
57798471,ORG,Soda Fabrik Vs. Levinstein
57798471,DATE,1887
57798471,CARDINAL,4
57798471,CARDINAL,449
57798471,CARDINAL,462
57798471,PERSON,Halsbury
57798471,GPE,L.C.
57798471,LAW,103/2012 Page 44
57798471,CARDINAL,106
57798471,ORG,American Cynamide
57798471,DATE,1889) 6
57798471,ORG,"RPC 243
> Edison & Swan Electric Light Co."
57798471,ORG,"Holland Lindley, J."
57798471,PERSON,Edison
57798471,DATE,1969
57798471,CARDINAL,20
57798471,PERSON,Halsbury
57798471,ORDINAL,3rd
57798471,CARDINAL,29
57798471,CARDINAL,123
57798471,ORG,Cipla
57798471,GPE,US
57798471,CARDINAL,45
57798471,CARDINAL,106
57798471,ORG,FAO
57798471,ORG,Merck Vs. Glenmark
57798471,ORG,Court
57798471,ORG,SPM
57798471,ORG,MSD
57798471,LAW,"Section
> 3(d"
57798471,LAW,the Act
57798471,LAW,Section 3(d)
57798471,CARDINAL,two
57798471,CARDINAL,96
57798471,DATE,1995
57798471,CARDINAL,255
57798471,GPE,United Kingdom
57798471,ORG,Glaverbel SA
57798471,ORG,British Coal Corp
57798471,CARDINAL,46
57798471,CARDINAL,106
57798471,CARDINAL,6
57798471,PERSON,Schuler
57798471,ORG,the House of Lords
57798471,ORG,Molins Vs. Industrial Machinery Co. Ltd.
57798471,DATE,1938
57798471,DATE,"55 RPC
> 31"
57798471,CARDINAL,97\
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,PRODUCT,Polymorph B
57798471,GPE,US
57798471,CARDINAL,221
57798471,PRODUCT,DEL ‗507
57798471,PERSON,Cipla
57798471,PRODUCT,Polymorphs A+B
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,GPE,Polymorph B
57798471,PERSON,Cipla
57798471,CARDINAL,98\
57798471,PERSON,Cipla
57798471,PERSON,Pravin Anand
57798471,ORG,Roche
57798471,ORG,"the
Learned Single Judge"
57798471,ORG,Defendant
57798471,ORG,"the Drug
Controller"
57798471,ORG,API
57798471,PRODUCT,Erlocip
57798471,ORG,Cipla
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,PRODUCT,Single Judge
57798471,ORG,Roche
57798471,ORG,Roche
57798471,PRODUCT,Tarceva
57798471,PRODUCT,Cipla
57798471,PRODUCT,Erlocip
57798471,ORG,Roche
57798471,CARDINAL,47
57798471,CARDINAL,106
57798471,PERSON,Cipla
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Roche
57798471,PRODUCT,Polymorph B
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,PRODUCT,Claim 1
57798471,PERSON,Sh.Pravin Anand
57798471,ORG,Roche
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Cipla
57798471,PRODUCT,Erlocip
57798471,ORDINAL,first
57798471,PRODUCT,H2O
57798471,ORG,Roche
57798471,WORK_OF_ART,"Claim
1 of Patent No"
57798471,CARDINAL,774
57798471,CARDINAL,"more
than one"
57798471,ORDINAL,first
57798471,CARDINAL,48
57798471,CARDINAL,106
57798471,PERSON,Sh.Pravin Anand
57798471,ORG,Roche
57798471,LAW,DW-2
57798471,ORG,Roche
57798471,PRODUCT,Tarceva
57798471,PRODUCT,"Polymorph B
of Erlotinib Hydrochloride"
57798471,GPE,US
57798471,CARDINAL,221
57798471,PRODUCT,Polymorph B
57798471,PERSON,Sh.Pravin Anand
57798471,ORG,Tarceva
57798471,LAW,Claim 1
57798471,CARDINAL,774
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,ORG,Tarceva
57798471,PRODUCT,Polymorph B
57798471,ORG,Roche
57798471,GPE,Tarceva
57798471,FAC,"Erlotinib
Hydrochloride"
57798471,CARDINAL,1
57798471,CARDINAL,774
57798471,ORG,the Learned Single Judge
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Chemical Name
57798471,ORG,International Union of Pure
57798471,ORG,IUPAC
57798471,ORG,Chemical Structure
57798471,ORG,International Non-Proprietary Names
57798471,ORG,INN
57798471,PRODUCT,Claim 1
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,PRODUCT,Chemical Name
57798471,ORG,IUPAC
57798471,PRODUCT,"Chemical
Structure"
57798471,ORG,INN
57798471,PERSON,Sh.Pravin Anand
57798471,PRODUCT,Polymorphic
57798471,ORDINAL,third
57798471,CARDINAL,49
57798471,CARDINAL,106
57798471,GPE,the United States
57798471,GPE,Tarceva
57798471,GPE,US
57798471,LAW,the Basic patent)
57798471,GPE,US
57798471,CARDINAL,221
57798471,PRODUCT,the Polymorph B
57798471,CARDINAL,100
57798471,PRODUCT,Polymorph B of Erlotinib Hydrochloride
57798471,ORDINAL,first
57798471,GPE,US
57798471,ORG,"Erlotinib
Hydrochloride"
57798471,GPE,Polymorph B
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORDINAL,first
57798471,GPE,Cipla
57798471,CARDINAL,213
57798471,PERSON,Tarceva
57798471,LAW,the Indian Patent
57798471,PRODUCT,Polymorphic
57798471,CARDINAL,103/2012
57798471,CARDINAL,50
57798471,CARDINAL,106
57798471,CARDINAL,102
57798471,CARDINAL,two
57798471,PERSON,Tarceva
57798471,ORDINAL,second
57798471,ORG,"Erlotinib
Hydrochloride"
57798471,CARDINAL,774
57798471,ORG,Tarceva
57798471,CARDINAL,774
57798471,ORG,Erlocip
57798471,CARDINAL,103
57798471,ORDINAL,second
57798471,CARDINAL,228
57798471,ORG,Court
57798471,CARDINAL,104
57798471,CARDINAL,230
57798471,CARDINAL,one
57798471,CARDINAL,105
57798471,CARDINAL,two
57798471,CARDINAL,774
57798471,LAW,103/2012 Page 51 of 106
57798471,CARDINAL,106
57798471,CARDINAL,107\
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,CARDINAL,108
57798471,ORG,the Division Bench
57798471,ORG,"the Gujarat
High Court"
57798471,DATE,2008 (37
57798471,CARDINAL,128
57798471,ORG,"Guj) Hind Mosaic and
Cement Works & Anr."
57798471,ORG,Shree Shahjanand Trading Corporation & Anr.
57798471,CARDINAL,103/2012
57798471,CARDINAL,52
57798471,CARDINAL,106
57798471,CARDINAL,109
57798471,PRODUCT,X-Ray
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,ORDINAL,third
57798471,CARDINAL,110
57798471,ORG,Roche
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Cipla
57798471,ORG,Court
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,CARDINAL,53
57798471,CARDINAL,106
57798471,CARDINAL,111
57798471,PERSON,Cipla
57798471,PRODUCT,"Polymorph B
(Erlocip"
57798471,CARDINAL,774
57798471,DATE,2008
57798471,PERSON,Servier
57798471,ORG,the Patents Court
57798471,ORG,the Court of Appeals
57798471,ORG,the Court of Appeals
57798471,PERSON,Servier
57798471,ORDINAL,third
57798471,CARDINAL,774
57798471,PRODUCT,"Polymorph B of
Erlotinib Hydrochloride"
57798471,PRODUCT,X-Ray
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,ORG,Cipla
57798471,ORG,Appellant
57798471,ORG,Respondent
57798471,ORDINAL,first
57798471,CARDINAL,112
57798471,ORG,Court
57798471,PRODUCT,Polymorph
57798471,ORG,Polymorph B
57798471,ORDINAL,third
57798471,CARDINAL,774
57798471,CARDINAL,54
57798471,CARDINAL,106
57798471,DATE,1969
57798471,CARDINAL,255
57798471,PRODUCT,F.H & B
57798471,ORG,Unichem
57798471,LAW,a Purposive Construction
57798471,CARDINAL,774
57798471,PRODUCT,Polymorphs A+B
57798471,CARDINAL,113\
57798471,CARDINAL,1
57798471,CARDINAL,774
57798471,CARDINAL,6
57798471,CARDINAL,3
57798471,CARDINAL,114
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Erlotinib Hydrochloride
57798471,GPE,Cipla
57798471,PRODUCT,Erlocip
57798471,CARDINAL,one
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,PRODUCT,Polymorph B)
57798471,PRODUCT,‗774
57798471,ORG,Tarceva
57798471,WORK_OF_ART,Erlocip
57798471,PRODUCT,Polymorph B
57798471,PRODUCT,"Erlotinib
Hydrochloride"
57798471,ORG,Cipla
57798471,PRODUCT,Claim 1
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,PRODUCT,Polymorph
57798471,CARDINAL,55
57798471,CARDINAL,106
57798471,LAW,Section 8 of The Patents Act
57798471,DATE,1970
57798471,CARDINAL,115
57798471,GPE,Cipla
57798471,LAW,"Section 8 of
the Patents Act."
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,PRODUCT,Polymorph B of Erlotinib Hydrochloride
57798471,PRODUCT,Polymorph B of Erlotinib Hydrochloride
57798471,LAW,IN `774
57798471,PRODUCT,"Polymorph
B of Erlotinib Hydrochloride"
57798471,GPE,US
57798471,CARDINAL,221
57798471,CARDINAL,116
57798471,PERSON,Cipla
57798471,LAW,Section 8
57798471,ORG,Controller
57798471,LAW,Section 8
57798471,LAW,Section 64 of the Patents Act
57798471,LAW,Section 64(1
57798471,ORG,Maj. (Retd
57798471,ORG,Sukesh Behl & Anr.
57798471,ORG,"Koninjlijke Phillips
Electronics 2015"
57798471,CARDINAL,61
57798471,CARDINAL,183
57798471,ORG,Maharashtra Sugar Mills
57798471,DATE,1950 SCR 536
57798471,ORG,"Ramji
Missar & Anr."
57798471,GPE,Bihar
57798471,DATE,1963
57798471,CARDINAL,2
57798471,CARDINAL,745
57798471,GPE,Uttar Pradesh
57798471,PERSON,Jogendar Singh
57798471,DATE,1964) 2
57798471,CARDINAL,197
57798471,PERSON,Sardar Govindrao
57798471,GPE,Madhya Pradesh
57798471,DATE,1965) 1
57798471,CARDINAL,678
57798471,PERSON,Nagar Nigam
57798471,ORG,Gorakhpur & Anr.
57798471,DATE,2008
57798471,CARDINAL,Nos.92/2012
57798471,CARDINAL,103/2012
57798471,CARDINAL,56
57798471,CARDINAL,106
57798471,CARDINAL,1282
57798471,CARDINAL,117
57798471,ORG,Roche
57798471,LAW,Section 8
57798471,PERSON,Cipla
57798471,PRODUCT,Polymorph B
57798471,CARDINAL,774
57798471,ORG,Roche
57798471,PRODUCT,Polymorph B
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,PRODUCT,"Polymorph B of Erlotinib
Hydrochloride"
57798471,CARDINAL,40
57798471,GPE,US
57798471,CARDINAL,221
57798471,GPE,USA
57798471,GPE,US
57798471,CARDINAL,221
57798471,PRODUCT,"Polymorph B of
Erlotinib Hydrochloride"
57798471,DATE,many years
57798471,CARDINAL,774
57798471,GPE,US
57798471,CARDINAL,221
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,Roche
57798471,LAW,Section 8
57798471,NORP,Indian
57798471,ORG,Roche
57798471,LAW,Section 3(d
57798471,LAW,"the
Patents Act"
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,the Patents Office
57798471,LAW,"Section
64"
57798471,CARDINAL,1
57798471,LAW,"RFA (OS)
Nos.92/2012 & 103/2012 Page 57 of 106"
57798471,ORG,Reliance
57798471,ORG,Sukesh Behl
57798471,CARDINAL,118\
57798471,ORG,Roche
57798471,LAW,Section 8
57798471,CARDINAL,2
57798471,LAW,Section 8
57798471,CARDINAL,119
57798471,CARDINAL,8
57798471,CARDINAL,64
57798471,QUANTITY,1)(m
57798471,LAW,the Patents Act
57798471,DATE,1970
57798471,LAW,Section 8
57798471,LAW,Act
57798471,GPE,India
57798471,ORG,Controller
57798471,CARDINAL,58
57798471,CARDINAL,106
57798471,GPE,India
57798471,ORG,Controller
57798471,GPE,India
57798471,GPE,India
57798471,GPE,India
57798471,CARDINAL,64
57798471,LAW,Act
57798471,LAW,"the
> commencement of this Act"
57798471,ORG,the Central Government
57798471,ORG,the Appellate Board
57798471,ORG,the High Court
57798471,LAW,section 8
57798471,CARDINAL,121\
57798471,ORG,Roche
57798471,CARDINAL,774
57798471,PRODUCT,"Polymorph
B"
57798471,ORG,Erlotinib Hydrochloride
57798471,DATE,"February 06, 2002"
57798471,CARDINAL,507
57798471,GPE,US
57798471,CARDINAL,221
57798471,CARDINAL,103/2012
57798471,CARDINAL,59
57798471,CARDINAL,106
57798471,CARDINAL,507
57798471,GPE,India
57798471,CARDINAL,40
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,Roche
57798471,ORG,Roche
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,Roche
57798471,CARDINAL,5
57798471,CARDINAL,219
57798471,ORG,FAO
57798471,DATE,about four years
57798471,CARDINAL,122\
57798471,DATE,2011) 9
57798471,ORG,"SCC 354 Delhi Airtech Services (P)
Ltd."
57798471,ORG,the Supreme Court
57798471,LAW,Statute
57798471,CARDINAL,116
57798471,ORDINAL,first
57798471,ORG,Court
57798471,LAW,Principles of Statutory Interpretation
57798471,DATE,"12th Edn., 2010"
57798471,ORG,G.P. Singh
57798471,CARDINAL,389-92
57798471,ORG,Supreme
57798471,ORG,RFA
57798471,CARDINAL,103/2012
57798471,CARDINAL,60
57798471,CARDINAL,106
57798471,CARDINAL,one
57798471,PERSON,Subbarao
57798471,CARDINAL,one
57798471,CARDINAL,118\
57798471,PERSON,Maxwell
57798471,LAW,Chapter 13
57798471,ORDINAL,12th
57798471,CARDINAL,314-15
57798471,CARDINAL,61
57798471,CARDINAL,106
57798471,ORDINAL,first
57798471,PERSON,Campbell
57798471,GPE,L.C.
57798471,PERSON,Penzance
57798471,LAW,Act
57798471,PERSON,Ed
57798471,ORG,"Howard
> v.Bodington"
57798471,DATE,1877
57798471,CARDINAL,203
57798471,CARDINAL,211
57798471,CARDINAL,42
57798471,CARDINAL,6
57798471,ORG,Court
57798471,DATE,2010
57798471,DATE,"13
> SCC 98"
57798471,CARDINAL,2010
57798471,CARDINAL,4
57798471,LAW,"103/2012 Page 62 of 106
> 774"
57798471,ORG,Court
57798471,ORG,Court
57798471,ORG,Court
57798471,ORG,State
57798471,CARDINAL,one
57798471,DATE,2010) 13 SCC 98
57798471,CARDINAL,2010
57798471,CARDINAL,4
57798471,CARDINAL,774
57798471,CARDINAL,103
57798471,CARDINAL,16
57798471,CARDINAL,16
57798471,GPE,Dattatraya
57798471,GPE,Moreshwar
57798471,DATE,"1952 SC 181 :
> 1952 Cri LJ 955"
57798471,ORG,Court
57798471,CARDINAL,103/2012
57798471,LAW,Page 63 of 106
57798471,CARDINAL,185
57798471,CARDINAL,7
57798471,CARDINAL,7
57798471,PERSON,Babu Ram Upadhya
57798471,DATE,AIR 1961 SC 751 : (1961) 1
57798471,WORK_OF_ART,Cri LJ 773
57798471,CARDINAL,765
57798471,CARDINAL,29
57798471,CARDINAL,29
57798471,CARDINAL,one
57798471,CARDINAL,22
57798471,DATE,(2000
57798471,DATE,7 SCC 679
57798471,ORG,Court
57798471,LAW,the Delhi Municipal Corporation Act
57798471,DATE,1957
57798471,ORG,"the Municipal
> Corporation"
57798471,LAW,Act
57798471,ORG,Corporation
57798471,ORG,Court
57798471,LAW,Page 64 of 106
57798471,ORG,Corporation
57798471,ORG,Corporation
57798471,CARDINAL,23
57798471,PERSON,Raghubir Dayal
57798471,DATE,(1995
57798471,CARDINAL,1
57798471,CARDINAL,133
57798471,ORG,Court
57798471,CARDINAL,135
57798471,CARDINAL,5
57798471,CARDINAL,5
57798471,ORG,Court
57798471,LAW,Act
57798471,LAW,Sections 11-A
57798471,CARDINAL,17
57798471,CARDINAL,3
57798471,LAW,Act
57798471,LAW,the Act
57798471,LAW,103/2012 Page 65 of 106 the ends of legislative intent
57798471,CARDINAL,123
57798471,ORG,Crawford on Statutory Construction
57798471,CARDINAL,one
57798471,CARDINAL,3
57798471,DATE,1999
57798471,DATE,2001
57798471,DATE,2 AC 91
57798471,CARDINAL,2001
57798471,CARDINAL,2
57798471,CARDINAL,56
57798471,CARDINAL,2001
57798471,CARDINAL,1
57798471,CARDINAL,577
57798471,LAW,Principles of Statutory Interpretation
57798471,DATE,"11th Edn., 2008"
57798471,CARDINAL,66
57798471,CARDINAL,106
57798471,CARDINAL,one
57798471,CARDINAL,two
57798471,PERSON,R.v. Jones
57798471,PERSON,Daunton
57798471,DATE,1963
57798471,CARDINAL,1
57798471,CARDINAL,270
57798471,CARDINAL,1963
57798471,CARDINAL,1
57798471,CARDINAL,368
57798471,GPE,India
57798471,PERSON,Maxwell
57798471,LAW,The Interpretation of Statutes
57798471,WORK_OF_ART,P. St. J. Langan
57798471,PERSON,Bullock
57798471,DATE,1964
57798471,CARDINAL,1
57798471,CARDINAL,481
57798471,DATE,1963
57798471,CARDINAL,3
57798471,CARDINAL,911
57798471,DATE,(1963
57798471,CARDINAL,3
57798471,CARDINAL,506
57798471,ORG,CCA
57798471,CARDINAL,123\
57798471,LAW,"RFA (OS)
Nos.92/2012 & 103/2012 Page 67 of 106 Section 64"
57798471,CARDINAL,1
57798471,ORG,Division Bench
57798471,ORG,Court
57798471,ORG,Maj.(Retd
57798471,LAW,"Sukesh Behl
(supra"
57798471,ORG,Court
57798471,LAW,Section 8(1) of the Patents Act
57798471,LAW,"and non-compliance of the
same is one of the grounds for revocation of the patent under Section
64(1)"
57798471,LAW,the use of the word ‗may' in Section 64(1)
57798471,ORG,Court
57798471,CARDINAL,124\
57798471,LAW,Section 64
57798471,CARDINAL,1
57798471,LAW,Section 8
57798471,DATE,1981
57798471,PERSON,Sharif-Ud-Din Vs.
57798471,PERSON,Abdul Gani Lone
57798471,ORG,the Supreme Court
57798471,CARDINAL,125
57798471,LAW,"RFA (OS)
Nos.92/2012 & 103/2012 Page 68 of 106 the object and purpose of the rule"
57798471,DATE,2011
57798471,CARDINAL,1
57798471,CARDINAL,236
57798471,ORG,Central Excise
57798471,PERSON,Hari Chand Shri Gopal
57798471,CARDINAL,126
57798471,ORG,Roche
57798471,CARDINAL,40
57798471,GPE,India
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,Roche
57798471,CARDINAL,two
57798471,ORG,Roche
57798471,GPE,US
57798471,CARDINAL,221
57798471,ORG,NATCO
57798471,CARDINAL,127
57798471,ORG,the Assistant Controller of Patents and Designs
57798471,DATE,"July 04, 2007"
57798471,GPE,US
57798471,CARDINAL,221
57798471,DATE,"July 04, 2007"
57798471,PRODUCT,EX-20 XRD
57798471,GPE,US
57798471,LAW,6900221
57798471,CARDINAL,11.11.99
57798471,CARDINAL,6
57798471,CARDINAL,69
57798471,CARDINAL,106
57798471,CARDINAL,128\
57798471,ORG,NATCO
57798471,PERSON,Cipla
57798471,ORG,Erlotinib Hydrochloride
57798471,GPE,US
57798471,CARDINAL,221
57798471,LAW,Section 8
57798471,ORG,Roche
57798471,GPE,US
57798471,CARDINAL,221
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,NATCO
57798471,GPE,US
57798471,LAW,`221
57798471,CARDINAL,129
57798471,LAW,Section 8 under Section 64
57798471,LAW,the Patents Act
57798471,CARDINAL,130
57798471,WORK_OF_ART,THE RISE OF LIFE
57798471,PERSON,Bill Bryson
57798471,WORK_OF_ART,‗A Short History of Nearly Everything'
57798471,ORDINAL,first
57798471,CARDINAL,"1,055"
57798471,GPE,Las Vegas
57798471,QUANTITY,about 27 metres
57798471,CARDINAL,"1,055"
57798471,CARDINAL,three
57798471,CARDINAL,four
57798471,CARDINAL,twenty
57798471,CARDINAL,one
57798471,CARDINAL,70
57798471,CARDINAL,"106 1,055"
57798471,CARDINAL,200
57798471,CARDINAL,200
57798471,CARDINAL,1
57798471,CARDINAL,10
57798471,CARDINAL,1
57798471,QUANTITY,260 zeros
57798471,CARDINAL,146
57798471,CARDINAL,10
57798471,ORG,Cambridge University
57798471,PERSON,Max Perutz
57798471,DATE,twenty- three years
57798471,CARDINAL,131
57798471,PERSON,Miller
57798471,PERSON,Harold Urey
57798471,PRODUCT,Saturn
57798471,CARDINAL,132
57798471,CARDINAL,two
57798471,CARDINAL,two
57798471,PERSON,"John
Newlands"
57798471,CARDINAL,71
57798471,CARDINAL,106
57798471,ORDINAL,eighth
57798471,PERSON,Newlands
57798471,PERSON,Law
57798471,PERSON,Newlands
57798471,CARDINAL,133\
57798471,DATE,1860
57798471,LOC,North America
57798471,CARDINAL,134\
57798471,PERSON,Dmitri Ivanovich Mendeleev
57798471,CARDINAL,one
57798471,CARDINAL,135
57798471,PERSON,Mendeleev
57798471,PERSON,"John
Newlands"
57798471,CARDINAL,136
57798471,CARDINAL,72
57798471,CARDINAL,106
57798471,CARDINAL,137\
57798471,PERSON,Robort E. Krebs
57798471,WORK_OF_ART,"„The History and Use Of Our Earth Chemical
Elements‟"
57798471,WORK_OF_ART,"the Periodic Table of the Chemical
Elements"
57798471,CARDINAL,138\
57798471,PERSON,Cipla
57798471,LAW,Section 64
57798471,LAW,the Patents Act
57798471,DATE,1970
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,CARDINAL,226
57798471,ORDINAL,first
57798471,PRODUCT,Quinazoline
57798471,CARDINAL,226
57798471,PERSON,Methyl
57798471,PERSON,Ethynyl
57798471,CARDINAL,3
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,CARDINAL,50
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,PERSON,Methyl
57798471,PERSON,Ethynyl
57798471,LAW,Grimm's Hydride Displacement Law
57798471,CARDINAL,20
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,CARDINAL,226
57798471,PERSON,Cyano
57798471,ORG,Reliance
57798471,ORG,Terrel on Patents
57798471,CARDINAL,550
57798471,CARDINAL,398
57798471,DATE,2007
57798471,ORG,KSR International Co. Vs. Teleflex Inc.
57798471,DATE,1985) R.P.C. 59
57798471,ORG,Tabur Marine (Great Britain) Ltd.
57798471,CARDINAL,2010
57798471,CARDINAL,18
57798471,CARDINAL,Nos.92/2012
57798471,CARDINAL,103/2012
57798471,CARDINAL,73
57798471,CARDINAL,106
57798471,DATE,2007
57798471,CARDINAL,588
57798471,CARDINAL,566
57798471,CARDINAL,999
57798471,DATE,2009
57798471,ORG,Altana Pharma AG Vs.
57798471,ORG,"Teva
Pharmaceuticals USA Ltd."
57798471,ORG,Boards of Appeal European Patent Office
57798471,ORG,Eisai Co. Ltd.
57798471,DATE,16 USPQ.2d 1897
57798471,GPE,Dillon
57798471,ORG,Merck
57798471,CARDINAL,138
57798471,CARDINAL,22
57798471,ORG,Zickendraht
57798471,ORG,Buehler
57798471,CARDINAL,82
57798471,CARDINAL,1321
57798471,ORG,Pfizer Inc Vs. Apotex Inc
57798471,CARDINAL,139
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,ORG,Cipla
57798471,CARDINAL,774
57798471,WORK_OF_ART,POSA
57798471,ORG,POSA
57798471,CARDINAL,two
57798471,LAW,103/2012 Page 74 of 106
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,CARDINAL,three
57798471,PERSON,Cipla
57798471,ORG,POSA
57798471,CARDINAL,51
57798471,CARDINAL,507
57798471,ORDINAL,3rd
57798471,WORK_OF_ART,"Methyl
on Phenyl ring"
57798471,ORDINAL,second
57798471,ORDINAL,3rd
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,ORDINAL,thirdly
57798471,CARDINAL,5
57798471,CARDINAL,two
57798471,ORG,DW-3 Prof
57798471,PERSON,Ashwini Nangia.
57798471,PERSON,Prof
57798471,PERSON,Ashwini Nangia DW-3
57798471,ORG,DW-3
57798471,ORG,Google
57798471,ORG,Wikipedia
57798471,ORG,Cipla
57798471,CARDINAL,226
57798471,CARDINAL,51
57798471,ORG,Cipla
57798471,PERSON,Roger Griffin
57798471,ORG,PW-2
57798471,PRODUCT,Erlotinib Hydrochloride
57798471,ORG,Reliance
57798471,DATE,1969
57798471,CARDINAL,75
57798471,CARDINAL,106
57798471,CARDINAL,255
57798471,DATE,1979
57798471,CARDINAL,2
57798471,CARDINAL,511
57798471,DATE,2012
57798471,DATE,EWHC 1848
57798471,ORG,"Mylan
Vs.Yeda"
57798471,GPE,MANU
57798471,ORG,Pfizer Inc. Vs.
57798471,ORG,Teva Pharmaceuticals
57798471,ORG,520 F.3d.
57798471,CARDINAL,1358
57798471,ORG,OrthoMcNeil Pharmaceutical Inc.
57798471,ORG,Mylan Laboratories Inc.
57798471,ORG,"Yamanouchi
Pharmaceutical Co. Ltd."
57798471,ORG,Danbury Pharmacal Inc.
57798471,GPE,MANU
57798471,GPE,Otsuka
57798471,ORG,Pharmaceutical Co. Ltd.
57798471,ORG,Sandoz Inc.
57798471,ORG,Apotex Inc.
57798471,CARDINAL,550
57798471,CARDINAL,398
57798471,DATE,2007
57798471,ORG,KSR International Co. Vs.
57798471,ORG,Teleflex Inc.
57798471,ORG,471 F.3d 1369 Eli Lilly And Company
57798471,ORG,Lilly Industries Ltd.
57798471,ORG,"Zenith Goldline Pharmaceuticals, Inc."
57798471,CARDINAL,1072
57798471,ORG,Cyclobenzaprine
57798471,CARDINAL,619
57798471,CARDINAL,1346
57798471,ORG,"Fed Cir 2010) Daiichi Sankyo Co.
Ltd."
57798471,ORG,Matrix Labs Ltd.
57798471,GPE,United States
57798471,ORG,District Court
57798471,ORG,"Civil
Action No.04-2355"
57798471,ORG,Altana Pharma
57798471,GPE,Kudco
57798471,CARDINAL,858
57798471,CARDINAL,341
57798471,ORG,OSI
57798471,ORG,Pharmaceuticals Vs. Mylan Pharmaceuticals Inc. & Pfizer Inc.
57798471,ORG,"Genentech Inc.
Vs."
57798471,ORG,Mylan Pharmaceuticals Inc.
57798471,ORG,Teaching of EP
57798471,CARDINAL,226
57798471,CARDINAL,851
57798471,CARDINAL,498
57798471,CARDINAL,507
57798471,PERSON,C.W. Thornber
57798471,ORG,Boards of Appeal
57798471,ORG,"the European
Patent Office"
57798471,LAW,No. T 0467/94
57798471,ORG,Eisai Co. Ltd.
57798471,ORG,"Boards
of Appeal"
57798471,ORG,the European Patent Office
57798471,CARDINAL,T0156/95
57798471,ORG,"Hoechst
Marion Inc."
57798471,ORG,Boards of Appeal
57798471,ORG,the European Patent Office
57798471,LAW,No. T 0643/96
57798471,ORG,Beecham Group PLC
57798471,CARDINAL,140\
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,76
57798471,CARDINAL,106
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,1
57798471,CARDINAL,141\
57798471,LAW,Section 64 of the Patents Act
57798471,DATE,1970
57798471,ORG,the Appellate Board
57798471,ORG,"the
High Court"
57798471,LAW,Act
57798471,LAW,Section 64(1
57798471,CARDINAL,64
57798471,CARDINAL,1
57798471,GPE,India
57798471,GPE,India
57798471,CARDINAL,142\
57798471,LAW,Section 64
57798471,CARDINAL,1
57798471,LAW,"the Patents Act,1970"
57798471,GPE,India
57798471,GPE,India
57798471,GPE,US
57798471,CARDINAL,774
57798471,DATE,"March 30, 1995"
57798471,GPE,US
57798471,CARDINAL,534
57798471,GPE,US
57798471,CARDINAL,766
57798471,CARDINAL,143\
57798471,CARDINAL,144\
57798471,LAW,103/2012 Page 77 of 106
57798471,DATE,1979
57798471,CARDINAL,2
57798471,CARDINAL,511
57798471,ORG,Hindustan Metal Industries
57798471,CARDINAL,25
57798471,ORG,"the Supreme
Court"
57798471,GPE,Halsbury
57798471,ORDINAL,3rd
57798471,DATE,Vol. 29
57798471,CARDINAL,42
57798471,ORG,Vimadalal
57798471,ORG,Bombay High Court
57798471,ORG,Farbwerke Hoechst & B. Corporation
57798471,ORG,"Unichem
> Laboratories"
57798471,DATE,1969 Bom 255
57798471,ORDINAL,first
57798471,CARDINAL,146
57798471,ORG,The Supreme Court of United States
57798471,CARDINAL,383
57798471,DATE,1966
57798471,PERSON,William T. Graham et al
57798471,ORG,John Deere Company
57798471,GPE,Kansas
57798471,CARDINAL,103/2012
57798471,CARDINAL,78
57798471,CARDINAL,106
57798471,CARDINAL,218
57798471,ORG,U.S. P.Q. 865 Environmental Designs Ltd.
57798471,ORG,Union Oil Company
57798471,GPE,California
57798471,CARDINAL,702
57798471,CARDINAL,1005
57798471,ORG,Orthopedic Equipment Co. Inc.
57798471,GPE,The United States
57798471,ORG,"Newell Companies, Inc."
57798471,ORG,"Kenney
Manufacturing Company"
57798471,ORG,"501 F.3d 1254Daiichi Sankyo Co., Ltd."
57798471,ORG,"Apotax,
Inc"
57798471,ORDINAL,first
57798471,CARDINAL,2
57798471,CARDINAL,5
57798471,CARDINAL,147
57798471,ORG,"the U.S. Supreme
Court"
57798471,ORG,KSR International Co
57798471,LAW,§ 103
57798471,LAW,Page 79 of 106
57798471,DATE,17-18
57798471,CARDINAL,148\
57798471,ORG,Windsurfing International Inc
57798471,ORG,the Court of Appeals
57798471,CARDINAL,four
57798471,ORG,Pozzoli SPA
57798471,CARDINAL,149
57798471,ORG,"Eisai Co., Ltd."
57798471,ORG,"the Board of Appeals of European Patent
Office"
57798471,CARDINAL,80
57798471,CARDINAL,106
57798471,CARDINAL,one
57798471,CARDINAL,150\
57798471,ORG,the Bombay High Court
57798471,ORG,F.H. & B. Corp.
57798471,ORG,Courts
57798471,ORG,Grain Processing
57798471,ORG,Court
57798471,ORG,Pfizer Inc. Vs.
57798471,ORG,"Teva
Pharmaceuticals"
57798471,ORG,Yamanouchi Pharmaceutical Co. Ltd.
57798471,ORG,Otsuka Pharmaceutical Co. Ltd.
57798471,CARDINAL,151
57798471,WORK_OF_ART,Step No.1
57798471,WORK_OF_ART,Step No.2
57798471,CARDINAL,81
57798471,CARDINAL,106
57798471,CARDINAL,152
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,CARDINAL,153\
57798471,ORG,Otsuka Pharmaceutical Co. Ltd.
57798471,CARDINAL,154
57798471,PERSON,Dillon
57798471,PERSON,Cipla
57798471,ORG,Courts
57798471,CARDINAL,82
57798471,CARDINAL,106
57798471,CARDINAL,581
57798471,PERSON,John R. Slemniski
57798471,ORG,Court
57798471,CARDINAL,155
57798471,ORG,Pfizer Inc.
57798471,ORG,Vs.Teva Pharmaceuticals
57798471,ORG,the Court of Appeals
57798471,ORG,"Allergan, Inc."
57798471,ORG,Sandoz Inc.
57798471,CARDINAL,726
57798471,CARDINAL,1286
57798471,CARDINAL,1290-91
57798471,DATE,2013
57798471,ORG,"Honeywell Int'l, Inc."
57798471,GPE,United States
57798471,CARDINAL,609
57798471,CARDINAL,1292
57798471,CARDINAL,1297
57798471,DATE,2010
57798471,CARDINAL,35
57798471,ORG,Allergan
57798471,DATE,1290-91
57798471,ORG,"Microsoft
> Corp."
57798471,ORG,i4i Ltd. P'ship
57798471,CARDINAL,131
57798471,CARDINAL,2238
57798471,CARDINAL,2242
57798471,DATE,2011
57798471,CARDINAL,two
57798471,ORDINAL,First
57798471,LAW,103/2012 Page 83 of 106
57798471,ORG,Eisai Co. v.
57798471,ORG,"Dr. Reddy's Labs., Ltd."
57798471,CARDINAL,1353
57798471,CARDINAL,1359
57798471,DATE,2008
57798471,ORG,"Takeda Chem. Indus.,
> Ltd."
57798471,ORG,"Alphapharm Pty., Ltd."
57798471,CARDINAL,492
57798471,CARDINAL,1350
57798471,CARDINAL,1357
57798471,DATE,2007
57798471,ORG,Eli Lilly & Co.
57798471,ORG,"Zenith Goldline Pharm., Inc."
57798471,CARDINAL,471
57798471,CARDINAL,1369
57798471,CARDINAL,1378
57798471,DATE,2006
57798471,ORG,Otsuka Pharm
57798471,ORG,"Co. v. Sandoz
> Inc."
57798471,CARDINAL,678
57798471,CARDINAL,1280
57798471,CARDINAL,1292
57798471,DATE,2012
57798471,ORG,Daichii Sankyo Co.
57798471,ORG,"Matrix
> Labs., Ltd."
57798471,CARDINAL,619
57798471,CARDINAL,1346
57798471,CARDINAL,1354
57798471,DATE,2010
57798471,ORG,Takeda
57798471,CARDINAL,1357
57798471,ORDINAL,second
57798471,DATE,1356-57
57798471,CARDINAL,156
57798471,ORG,Eli Lilly And Company
57798471,ORG,Lilly Industries Ltd.
57798471,ORG,"the Court of
Appeals"
57798471,ORG,Yamanouchi Pharm
57798471,PERSON,Kahn
57798471,CARDINAL,977
57798471,CARDINAL,986
57798471,DATE,2006
57798471,GPE,Rouffet
57798471,CARDINAL,1350
57798471,CARDINAL,1355
57798471,DATE,1998
57798471,CARDINAL,84
57798471,CARDINAL,106
57798471,PERSON,Lilly
57798471,ORG,Lilly
57798471,CARDINAL,four
57798471,CARDINAL,five
57798471,CARDINAL,852-74
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,3
57798471,CARDINAL,4
57798471,CARDINAL,852-53
57798471,DATE,1975
57798471,DATE,1990
57798471,CARDINAL,832-34
57798471,CARDINAL,906
57798471,PRODUCT,Compound `222
57798471,CARDINAL,73
57798471,CARDINAL,157
57798471,ORG,Courts
57798471,LAW,Rule
57798471,CARDINAL,85
57798471,CARDINAL,106
57798471,PERSON,Dillon
57798471,CARDINAL,158\
57798471,CARDINAL,159
57798471,PERSON,Cipla
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,CARDINAL,50
57798471,CARDINAL,51
57798471,CARDINAL,2
57798471,QUANTITY,0.834 g
57798471,CARDINAL,6
57798471,QUANTITY,10 ml
57798471,TIME,16 hours
57798471,QUANTITY,4 ml
57798471,CARDINAL,59.8
57798471,CARDINAL,"H,6.4"
57798471,CARDINAL,9.9
57798471,CARDINAL,C21H25N3O4
57798471,CARDINAL,6.2
57798471,PERCENT,10.0%
57798471,CARDINAL,160
57798471,PERSON,Markush Formla
57798471,CARDINAL,226
57798471,CARDINAL,86
57798471,CARDINAL,106
57798471,CARDINAL,161
57798471,LAW,EP ‗226
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,162\
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,LAW,EP ‗507
57798471,ORG,POSA
57798471,ORDINAL,3rd
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,LAW,EP ‗507
57798471,QUANTITY,6-position
57798471,QUANTITY,5- or 6-membered
57798471,CARDINAL,one
57798471,CARDINAL,two
57798471,CARDINAL,87
57798471,CARDINAL,106
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,3
57798471,CARDINAL,163\
57798471,ORG,Cipla
57798471,ORDINAL,3rd
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,WORK_OF_ART,Grimm's Hydride Displacement
57798471,CARDINAL,1
57798471,PERSON,Grimm
57798471,CARDINAL,88
57798471,CARDINAL,106
57798471,CARDINAL,165
57798471,PERSON,Ashwani Nagia
57798471,PERSON,Cipla
57798471,CARDINAL,507
57798471,PERSON,DW-3
57798471,ORG,"the School of Chemistry, University of
Hyderabad"
57798471,ORG,Yale University
57798471,ORG,Chemistry
57798471,DATE,over 20 years
57798471,ORG,DW-3
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,GPE,US
57798471,ORG,DW-3
57798471,CARDINAL,one
57798471,PRODUCT,Erlotinib
57798471,GPE,US
57798471,CARDINAL,166
57798471,LAW,DW-3
57798471,CARDINAL,5
57798471,CARDINAL,774
57798471,CARDINAL,226
57798471,LAW,EP `226
57798471,CARDINAL,774
57798471,CARDINAL,18
57798471,CARDINAL,226
57798471,CARDINAL,89
57798471,CARDINAL,106
57798471,CARDINAL,226
57798471,PRODUCT,Astra Zeneca
57798471,CARDINAL,226
57798471,ORG,EP
57798471,CARDINAL,226
57798471,ORG,Astra Zeneca
57798471,CARDINAL,226
57798471,CARDINAL,774
57798471,LAW,EP `226
57798471,CARDINAL,226
57798471,CARDINAL,774
57798471,CARDINAL,90
57798471,CARDINAL,106
57798471,CARDINAL,9\
57798471,CARDINAL,two
57798471,ORDINAL,3rd
57798471,CARDINAL,226
57798471,CARDINAL,774
57798471,CARDINAL,two
57798471,ORDINAL,3rd
57798471,GPE,US
57798471,GPE,US
57798471,CARDINAL,one
57798471,CARDINAL,700
57798471,CARDINAL,three
57798471,CARDINAL,1
57798471,CARDINAL,2
57798471,CARDINAL,3
57798471,CARDINAL,2
57798471,CARDINAL,700
57798471,CARDINAL,91
57798471,CARDINAL,106
57798471,GPE,US
57798471,CARDINAL,590
57798471,GPE,US
57798471,FAC,590
57798471,CARDINAL,one
57798471,GPE,US
57798471,CARDINAL,766
57798471,CARDINAL,3
57798471,CARDINAL,14
57798471,GPE,US
57798471,CARDINAL,534
57798471,ORG,Pfizer
57798471,PERSON,Lee
57798471,PERSON,D. Arnold
57798471,CARDINAL,one
57798471,CARDINAL,two
57798471,CARDINAL,774
57798471,GPE,US
57798471,CARDINAL,200259
57798471,DATE,"Feb 23, 1994"
57798471,CARDINAL,774
57798471,DATE,"June
> 6, 1995"
57798471,CARDINAL,774
57798471,PERSON,Arnold
57798471,CARDINAL,4
57798471,CARDINAL,774
57798471,PERSON,Arnold
57798471,CARDINAL,4
57798471,PERSON,Arnold
57798471,CARDINAL,774
57798471,ORDINAL,3rd
57798471,CARDINAL,226
57798471,GPE,US
57798471,CARDINAL,736534
57798471,CARDINAL,92
57798471,CARDINAL,106
57798471,ORDINAL,3rd
57798471,CARDINAL,774
57798471,CARDINAL,half
57798471,ORG,Defendant
57798471,CARDINAL,774
57798471,CARDINAL,226
57798471,CARDINAL,167
57798471,PERSON,DW-3
57798471,PERSON,No.51
57798471,LAW,Example 51 of EP ‗226
57798471,LAW,EP `226
57798471,CARDINAL,4
57798471,CARDINAL,93
57798471,CARDINAL,106
57798471,ORG,Google
57798471,ORG,Wikipedia
57798471,DATE,a few days
57798471,ORG,Google
57798471,ORG,Wikipedia
57798471,CARDINAL,168\
57798471,PERSON,DW-3
57798471,ORG,Chemistry
57798471,CARDINAL,774
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,GPE,US
57798471,CARDINAL,221
57798471,CARDINAL,226
57798471,ORG,DW-3
57798471,ORG,Cipla
57798471,GPE,US
57798471,GPE,US
57798471,GPE,US
57798471,CARDINAL,507
57798471,CARDINAL,51
57798471,CARDINAL,226
57798471,CARDINAL,774
57798471,PERSON,Grimm
57798471,CARDINAL,94
57798471,CARDINAL,106
57798471,ORG,DW-3
57798471,ORG,Google
57798471,ORG,Wikipedia
57798471,PERSON,DW-3
57798471,LAW,"EP
`226"
57798471,ORG,DW-3
57798471,LAW,Example 51 of EP `226
57798471,PERSON,DW-3's
57798471,ORG,DW-3's
57798471,ORG,DW-3
57798471,CARDINAL,700
57798471,GPE,US
57798471,GPE,US
57798471,PRODUCT,US `534
57798471,ORG,DW-3
57798471,CARDINAL,95
57798471,CARDINAL,106
57798471,CARDINAL,five
57798471,PRODUCT,EP `700
57798471,GPE,US
57798471,CARDINAL,590
57798471,PRODUCT,US ‗766
57798471,PRODUCT,WO ‗0047
57798471,GPE,US
57798471,CARDINAL,534
57798471,DATE,"August 31, 1995"
57798471,CARDINAL,169
57798471,GPE,Cipla
57798471,ORG,Roche
57798471,ORG,DW-3
57798471,ORG,Cipla
57798471,CARDINAL,170\
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,CARDINAL,16
57798471,PERSON,Cipla
57798471,LAW,application number 537/DEL/1996
57798471,GPE,India
57798471,DATE,"March 13, 1996"
57798471,CARDINAL,one
57798471,ORG,"Pfizer
Inc."
57798471,GPE,U.S.
57798471,DATE,"March 30, 1995"
57798471,PRODUCT,Quinazoline Derivatives‖
57798471,ORG,Roche
57798471,ORG,Roche
57798471,ORG,‗Right to Sue‟
57798471,LAW,Section 64 of the Patents Act
57798471,PERSON,Cipla
57798471,ORG,F. Hoffmann-La Roche Ltd.
57798471,ORG,Roche)  RFA
57798471,CARDINAL,96
57798471,CARDINAL,106
57798471,ORG,"No.1 and OSI Pharmaceuticals, Inc."
57798471,ORG,OSI
57798471,ORG,Roche
57798471,ORG,OSI
57798471,ORG,OSI
57798471,ORG,Pfizer Products
57798471,ORG,OSI
57798471,ORG,"M/s Pfizer
Products Inc."
57798471,PRODUCT,Erlotinib
57798471,DATE,"March 13, 1996"
57798471,ORG,OSI
57798471,ORG,M/s Pfizer Inc
57798471,ORG,M/s Pfizer Product Inc
57798471,ORG,Roche
57798471,LAW,"Development, Collaboration and Licensing
Agreement"
57798471,ORG,OSI
57798471,ORG,Roche
57798471,ORG,Erlotinib
57798471,ORG,Pfizer Inc.
57798471,ORG,"Pfizer Product
Inc."
57798471,ORG,OSI
57798471,ORG,Pfizer Product Inc.
57798471,ORDINAL,first
57798471,DATE,"May 18, 2005"
57798471,ORG,"Pfizer
Inc."
57798471,ORG,Pfizer Product Inc.
57798471,ORDINAL,second
57798471,ORG,Pfizer Product Inc.
57798471,ORG,OSI
57798471,ORDINAL,first
57798471,DATE,"May 18, 2005"
57798471,DATE,"May 03, 2004"
57798471,ORDINAL,second
57798471,DATE,"May 05,
2004"
57798471,DATE,"August 12, 2005"
57798471,DATE,"May 05, 2004"
57798471,ORDINAL,first
57798471,DATE,"May 18, 2005"
57798471,ORG,Roche
57798471,LAW,Sections 20
57798471,CARDINAL,50
57798471,CARDINAL,68
57798471,CARDINAL,69
57798471,LAW,the Patents Act
57798471,ORG,RFA
57798471,CARDINAL,103/2012
57798471,LAW,Page 97 of 106
57798471,ORG,OSI
57798471,DATE,"May 05, 2004"
57798471,ORG,Roche
57798471,CARDINAL,171
57798471,ORG,Roche
57798471,LAW,Section 64 of the Patents Act
57798471,LAW,Section 64
57798471,CARDINAL,774
57798471,PERSON,Cipla
57798471,LAW,"the Register of Patents under
Section 71 of the Patents Act"
57798471,ORG,the Intellectual Property Appellate Board
57798471,ORG,IPAB
57798471,LAW,Section 71
57798471,LAW,Sections 117C
57798471,LAW,117D of the Patents Act
57798471,ORG,Court
57798471,ORG,Roche
57798471,ORG,Pfizer Inc.
57798471,DATE,"March 13, 1996"
57798471,DATE,"May 18, 2005"
57798471,DATE,"May 03, 2004"
57798471,ORG,Pfizer Inc
57798471,ORG,Pfizer Product Inc.
57798471,DATE,"May 05, 2004"
57798471,ORG,"Pfizer
Product Inc"
57798471,ORG,OSI
57798471,ORG,OSI
57798471,ORG,Pfizer Inc
57798471,ORG,OSI
57798471,DATE,"April 01, 1986"
57798471,DATE,"April
01, 1991"
57798471,DATE,"April 01, 1996"
57798471,LAW,"103/2012 Page
98"
57798471,CARDINAL,106
57798471,DATE,"July 06, 2007"
57798471,DATE,"February 23, 2007"
57798471,ORG,Pfizer Product Inc.
57798471,ORG,OSI
57798471,DATE,"January
08, 2001"
57798471,ORG,OSI
57798471,ORG,Roche
57798471,DATE,"September 07, 2008"
57798471,ORG,Roche
57798471,ORG,Pfizer Product Inc.
57798471,ORG,OSI
57798471,DATE,"January 08, 2001"
57798471,LAW,Collaborative Research Agreement
57798471,DATE,Ex.PW1/4
57798471,DATE,2003
57798471,ORG,Mahinder Singh & Ors.
57798471,ORDINAL,third
57798471,CARDINAL,172\
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,LAW,Section 64 of the Patents Act
57798471,ORG,CIPLA
57798471,ORG,OPP
57798471,ORG,CIPLA
57798471,LAW,Section 117C
57798471,LAW,117D of the Patents Act
57798471,CARDINAL,173\
57798471,LAW,Section 71
57798471,ORG,Register
57798471,LAW,Section 117C
57798471,ORG,the Appellate Board
57798471,LAW,Section 71
57798471,LAW,Section 117C
57798471,ORG,the Civil Court
57798471,CARDINAL,117C
57798471,CARDINAL,117D
57798471,CARDINAL,71
57798471,LAW,"Appellate Board - (1) The Appellate Board
>"
57798471,CARDINAL,99
57798471,CARDINAL,106
57798471,ORG,the Appellate Board
57798471,ORG,Appellate Board
57798471,ORG,Controller
57798471,ORG,Board
57798471,ORG,the Appellate Board
57798471,ORG,Controller
57798471,CARDINAL,117C
57798471,CARDINAL,2
57798471,CARDINAL,117A
57798471,CARDINAL,117D
57798471,CARDINAL,117D
57798471,ORG,"Appellate
> Board"
57798471,LAW,Board under section 64
57798471,ORG,the Appellate Board
57798471,LAW,section 71
57798471,LAW,Act
57798471,ORG,Board
57798471,ORG,Controller
57798471,ORG,Board
57798471,CARDINAL,100
57798471,CARDINAL,106
57798471,CARDINAL,174
57798471,ORG,Court
57798471,CARDINAL,175
57798471,ORG,CIPLA
57798471,CARDINAL,537
57798471,ORG,Pfizer Inc.
57798471,ORG,"Pfizer
Products Inc."
57798471,ORG,OSI Pharmaceuticals Inc.
57798471,ORG,OSI
57798471,DATE,/10
57798471,ORG,Ex.DW4/43
57798471,ORG,Controller of Patents
57798471,LAW,Form 2A
57798471,ORG,Pfizer Inc.
57798471,PERSON,Rodney Caughren Schnur
57798471,PERSON,Lee Daniel Arnold
57798471,DATE,"March 13, 1996"
57798471,DATE,"March 30, 1995"
57798471,GPE,USA
57798471,GPE,India
57798471,ORG,Pfizer Inc
57798471,DATE,"May 18,
2005"
57798471,DATE,"May 03, 2004"
57798471,ORG,Pfizer Products Inc.
57798471,PRODUCT,Ex.DW4/1
57798471,DATE,"May 05, 2004"
57798471,ORG,Pfizer Product Inc.
57798471,ORG,OSI
57798471,ORG,Pfizer Product Inc.
57798471,ORG,OSI
57798471,PRODUCT,Ex.DW4/1
57798471,DATE,"July 06,
2007"
57798471,ORG,Pfizer Product Inc.
57798471,ORG,OSI
57798471,CARDINAL,176
57798471,PERSON,Cipla
57798471,CARDINAL,two
57798471,DATE,"May 18, 2005"
57798471,DATE,"May 05,
2004"
57798471,DATE,1998) 7
57798471,ORG,"SCC 348 Life Insurance
Corporation of India"
57798471,ORG,Dharam Vir Anand Supreme Court
57798471,CARDINAL,103/2012
57798471,CARDINAL,101
57798471,CARDINAL,106
57798471,CARDINAL,177\
57798471,PERSON,Cipla
57798471,ORG,Pfizer Inc.
57798471,ORG,Pfizer Products Inc.
57798471,ORG,Pfizer Inc.
57798471,ORG,Pfizer Products Inc.
57798471,DATE,"May 18, 2005"
57798471,ORG,OSI
57798471,CARDINAL,774
57798471,DATE,"February
23, 2007"
57798471,ORG,OSI
57798471,CARDINAL,178\
57798471,LAW,The Registration Act
57798471,DATE,2004) 13 SCC 49
57798471,ORG,Vikshara Trading & Investment (P) Ltd.
57798471,ORG,the Supreme Court
57798471,CARDINAL,179
57798471,PERSON,Cipla
57798471,LAW,Section 50 of the Patents Act
57798471,ORG,Roche
57798471,ORG,Roche
57798471,ORG,OSI
57798471,DATE,"January 08, 2001"
57798471,ORG,Roche
57798471,ORG,Pfizer Products Inc.
57798471,ORG,OSI
57798471,DATE,"September 04, 2008"
57798471,PERSON,Cipla
57798471,LAW,Development Collaboration and Licensing Agreement
57798471,DATE,"January
08, 2001"
57798471,ORG,Roche
57798471,ORG,OSI
57798471,ORG,RFA
57798471,CARDINAL,103/2012
57798471,CARDINAL,102
57798471,CARDINAL,106
57798471,ORG,Cipla
57798471,PERSON,Cipla
57798471,ORG,Roche
57798471,ORG,Roche
57798471,CARDINAL,180\
57798471,ORG,Roche
57798471,ORG,OSI
57798471,DATE,2007) 2
57798471,CARDINAL,551
57798471,PERSON,Lata Nahata
57798471,PERSON,Chandi Prasad Sikaria
57798471,ORG,the Supreme Court
57798471,ORG,Court
57798471,LAW,Section 99
57798471,ORG,CPC
57798471,CARDINAL,181\
57798471,ORG,the Madras High Court
57798471,DATE,2014
57798471,ORG,SCC OnLine Mad 163 M.C. Jayasingh Vs. Mishra Dhatu Nigam Ltd.
57798471,LAW,Sections 48
57798471,CARDINAL,50
57798471,CARDINAL,51
57798471,LAW,the Patents Act
57798471,DATE,1970
57798471,CARDINAL,29
57798471,CARDINAL,30
57798471,CARDINAL,1
57798471,LAW,Section 50 of the Patents Act
57798471,DATE,1970
57798471,CARDINAL,two
57798471,LAW,the RFA (OS) Nos.92/2012
57798471,LAW,"103/2012 Page 103
> of 106"
57798471,LAW,"Sub-Section (1), the Act"
57798471,LAW,Sub-Section (3) of Section 50
57798471,LAW,Section 51
57798471,LAW,Act
57798471,LAW,Sub-Section (2) of Section 50
57798471,CARDINAL,2
57798471,LAW,Section 50
57798471,LAW,Section 51
57798471,CARDINAL,two
57798471,LAW,Section 48
57798471,LAW,Section 48 of the Act
57798471,ORDINAL,third
57798471,ORDINAL,third
57798471,CARDINAL,2
57798471,LAW,Section 50
57798471,LAW,Section 48
57798471,LAW,"Section
> 48"
57798471,LAW,Section 50
57798471,CARDINAL,3
57798471,CARDINAL,104
57798471,CARDINAL,106
57798471,LAW,Section 50(2
57798471,CARDINAL,one
57798471,CARDINAL,182\
57798471,LAW,Section 48 of the Patents Act
57798471,DATE,1970
57798471,ORG,OSI
57798471,ORG,No.2
57798471,LAW,Section 50 of the Patents Act
57798471,ORG,Roche
57798471,ORG,OSI
57798471,ORG,No.2
57798471,LAW,"Section 64 of the
Patents Act"
57798471,PERSON,Cipla
57798471,CARDINAL,183\
57798471,DATE,"September
07, 2012"
57798471,PERSON,Cipla
57798471,LAW,IN ‗577
57798471,ORG,Roche
57798471,ORG,Roche
57798471,ORG,Roche
57798471,GPE,India
57798471,DATE,"March, 2016"
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,ORG,Erlocip
57798471,ORG,Cipla
57798471,PRODUCT,Erlocip
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,CARDINAL,105
57798471,CARDINAL,106
57798471,ORG,Joint Registrar
57798471,ORG,Cipla
57798471,ORG,Joint Registrar
57798471,ORG,RFA
57798471,CARDINAL,184\
57798471,ORG,Roche
57798471,ORG,Cipla
57798471,CARDINAL,"5,00,000"
57798471,DATE,"NOVEMBER 27, 2015
    Mamta/ vkm"
57798471,CARDINAL,106
57798471,CARDINAL,106
